Start / PharmaTalkRadio / Current and emerging drug delivery needs in oncology

PharmaTalkRadio

Current and Emerging Drug Delivery Needs in Oncology

58 min • 4 juni 2018

Drug Delivery Needs in Oncology Due to the increasing number of parenteral biologic therapies that are administered intravenously, the already high pressure on infusion capacity and healthcare resources is expected further increase. A change from intravenous to subcutaneous dosing has been shown to reduce dosing complexity and overall drug administration related costs. There is keen interest in technologies that facilitate subcutaneous administration and potentially enable drug administration in the home setting. Led by: Beate Bittner, PhD Portfolio Strategy Director, Roche Panelists: Panel: H Janice Adkins, MBA Associate Director Marketing, BD Medical The exp Pharmaceutical Systems, North America EMEA Ulrich Bruggemann Head Academics and Innovation, Global Medical Devices of the Development, Sanofi US Shawn Davis, PhD Director, Technology Strategy and Innovation, Amgen Declan Reilly Section Head, Device Engineering, Device Development PTDE-D, Roche Andrew J Yee, MD Medical Oncologist, Massachusetts General Hospital Cancer Center This presentation took place at the 7th Annual Partnership Opportunities in Drug Delivery (PODD) 2017.

Senaste avsnitt

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

14 augusti | 29 min

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00